VAERS Explorer
Back to explore

Report #2833522

Received Jul 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
KS
Recovered
Unknown
Vaccinated
Mar 18, 2021
Onset
Mar 18, 2021
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH2EP7534RA
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECHUNKEP7534—

Symptoms (7)

Body temperatureCOVID-19Drug ineffectiveExpired product administeredFatigueMyalgiaPyrexia

Symptom narrative

muscle aches; fever of 102; extreme fatigue; expiration date: 31Jan2021, vaccination date: 18Mar2021; This is a spontaneous report received from a Consumer or other non HCP from product quality group. A patient (age and gender not provided) received BNT162b2 (BNT162B2), on 18Mar2021 as dose number unknown, single (Lot number: EP7534, Expiration Date: 31Jan2021) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EXPIRED PRODUCT ADMINISTERED (non-serious) with onset 18Mar2021, outcome "unknown", described as "expiration date: 31Jan2021, vaccination date: 18Mar2021"; MYALGIA (non-serious), outcome "unknown", described as "muscle aches"; PYREXIA (non-serious), outcome "unknown", described as "fever of 102"; FATIGUE (non-serious), outcome "unknown", described as "extreme fatigue". Additional information: Patient reported that patient gets terribly sick (muscle aches, fever of 102 and extreme fatigue) when patient got the COVID shot every time. Patient wanted to know what was error in the medicine. Follow-up (14Jul2025): This is a spontaneous follow-up report received from a consumer.Updated information included: New events (muscle ache, fever, fatigue) and additional information. Amendment: This follow-up report is being submitted to amend previous information: Removed at-risk classification.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500065348 Same patient/vaccine, different dose/event;